Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Squamous Cell » Squamous Cell Carcinoma of Head and Neck
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Squamous Cell Carcinoma of Head and Neck
Description
The most common type of head and neck carcinoma that originates from cells on the surface of the NASAL CAVITY; MOUTH; PARANASAL SINUSES, SALIVARY GLANDS, and LARYNX. Mutations in TNFRSF10B, PTEN, and ING1 genes are associated with this cancer. MeSH
Hierarchy View
Phase 3 Indicated Drugs (53)
Phase 1 Indicated Drugs (196)
autologous, engineered t cells targeting tp53 r175h
autologous monocyte-derived dendritic cells transfected with dna
modified vaccinia virus ankara vaccine expressing p53
oncolytic measles virus encoding thyroidal sodium iodide symporter
Other Experimental Indicated Drugs (31)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (56)
Associazione Volontari Pazienti Oncologici
Chinese Academy of Medical Sciences
Clinica Universidad de Navarra
DAHANCA Danish Head and Neck Group
Danish Center for Interventional Research in Radiation Oncology
GORTEC (Head and Neck Oncology and Radiotherapy Group)
Groupe Oncologie Radiotherapie Tete et Cou
GROUPE ONCOLOGIE RADIOTHERAPIE TETE ET COU
Grupo de Investigación Clínica en Oncología Radioterapia
Gruppo Oncologico del Nord-Ovest
Organization Involved with Phase 2 Indications (254)
All India Institute of Medical Sciences
Badalona Hospital Germans Trias i Pujol
Beijing Konruns Pharmaceutical Co., Ltd.
Bhagwan Mahaveer Jain Hospital
Biotech Pharmaceutical Co., Ltd.
Central India Cancer Research Institute, Nagpur
Christian Medical College, Vellore, India
CSM Medical University, Lucknow
Curie Manavata Cancer Center, Nashik, India
Deenanath Mangeshkar Hospital & Research Centre
Department of Radiation Oncology
Dynavax Technologies Corporation
Eastern Cooperative Oncology Group
ECOG-ACRIN Cancer Research Group
Elisabeth-TweeSteden Ziekenhuis
GKNM Hospital, Coimbatore, India
Gottfried Wilhelm Leibniz Universität Hannover
Government Medical College, Aurangabad, India
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Hellenic Cooperative Oncology Group
HonorHealth Research Institute
Hoosier Cancer Research Network
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Instituto do Cancer do Estado de São Paulo
Istituto Oncologico Veneto IRCCS
James and Esther King Biomedical Research Program
Jaslok Hospital and Research Centre, Mumbai, India
Jiangsu Cancer Institute & Hospital
Lithuanian University of Health Sciences
Meenakshi Ammal Dental College and Hospital
Memorial Hermann Health System
National Cancer Institute, France
National Comprehensive Cancer Network
National Institute of Dental and Craniofacial Research (NIDCR)
National Institutes of Health (NIH)
National University of Singapore
People's Liberation Army of China
Pharmaceutical Research Associates, Inc. (PRA)
Regional Cancer Centre, Trivandram
Royal Marsden Hospital NHS Trust
Samyang Biopharmaceuticals Corporation
Shanghai Junshi Bioscience Co.,Ltd.
Universidad Complutense de Madrid
Université catholique de Louvain
University of Alabama, Birmingham
University of California, Davis
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Erlangen-Nuremberg
University of Nice Sophia Antipolis
University of North Carolina at Chapel Hill
University of Southern California
University of Texas at Houston
University of Texas, San Antonio
Organization Involved with Phase 1 Indications (70)
Baromedical Research Foundation
British Columbia Cancer Agency
Cancer Immunotherapy Trials Network
Case Western Reserve University
Medical University of South Carolina
Memorial Sloan-Kettering Cancer Center
Methodist Cancer Center, Houston, Texas
National Institute on Deafness and Other Communication Disorders (NIDCD)
Organization Involved with Other Experimental Indications (5)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
